Rwanda
Rwandan health authorities have issued a recall for antifungal tablets produced in Kenya due to safety concerns.
The Rwanda Food and Drugs Authority (RFDA) has directed importers to return all batches of 200mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
Retailers and health facilities are instructed to cease distribution and return the affected drugs.
The RFDA's action comes after notifying the Kenyan manufacturer about discolouration in the tablets. Four bulk batches of pink Fluconazole 200mg tablets, imported into Rwanda, exhibited white discolouration shortly after their shelf life began.
The agency emphasized that some of these discoloured tablets had already entered the Rwandan market. Health officials in Rwanda are launching an investigation to determine whether these drugs have had any adverse effects on consumers.
Meanwhile, Kenyan authorities have not yet announced whether the antifungal drug, commonly used to treat fungal or yeast infections, will also be recalled from the local market.
02:37
World Diabetes Day: South African health leaders urge early action to detect the disease
01:07
Nigeria Ebola patient contacts complete 21-day monitoring without signs of infection
10:00
South Africa: ANC Loses Ground, Coalition Talks Take Centre Stage [Africanews Today]
01:49
Kenyan authorities seize 454kg of crystal meth worth $27 million
01:00
DR Congo: MSF celebrates Ebola patient discharges in Ituri province
01:15
Nigeria evacuates Ebola patient to Switzerland, tracks 53 contacts